TIAA CREF Investment Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-228,405
| Closed | -$3.8M | – | 3084 |
|
|
2017
Q3 | $3.8M | Hold |
228,405
| – | – | ﹤0.01% | 1791 |
|
|
2017
Q2 | $4.09M | Buy |
228,405
+58,900
| +35% | +$1.1M | ﹤0.01% | 1728 |
|
|
2017
Q1 | $3.4M | Sell |
169,505
-5,336
| -3% | -$124K | ﹤0.01% | 1821 |
|
|
2016
Q4 | $4.38M | Buy |
174,841
+50,232
| +40% | +$1.19M | ﹤0.01% | 1691 |
|
|
2016
Q3 | $2.91K | Buy |
124,609
+24,243
| +24% | +$570K | ﹤0.01% | 1955 |
|
|
2016
Q2 | $2.01M | Buy |
100,366
+32,807
| +49% | +$612K | ﹤0.01% | 2122 |
|
|
2016
Q1 | $1.14M | Sell |
67,559
-23,819
| -26% | -$488K | ﹤0.01% | 2400 |
|
|
2015
Q4 | $2.03M | Buy |
91,378
+6,253
| +7% | +$130K | ﹤0.01% | 2142 |
|
|
2015
Q3 | $1.45M | Hold |
85,125
| – | – | ﹤0.01% | 2346 |
|
|
2015
Q2 | $1.17M | Sell |
85,125
-2,547
| -3% | -$33.8K | ﹤0.01% | 2623 |
|
|
2015
Q1 | $1.2M | Hold |
87,672
| – | – | ﹤0.01% | 2516 |
|
|
2014
Q4 | $927K | Sell |
87,672
-7,014
| -7% | -$83K | ﹤0.01% | 2692 |
|
|
2014
Q3 | $1.18M | Sell |
94,686
-16,730
| -15% | -$233K | ﹤0.01% | 2538 |
|
|
2014
Q2 | $1.52M | Sell |
111,416
-13,570
| -11% | -$177K | ﹤0.01% | 2461 |
|
|
2014
Q1 | $1.51M | Buy |
124,986
+8,240
| +7% | +$94.4K | ﹤0.01% | 2402 |
|
|
2013
Q4 | $1.44M | Buy |
116,746
+6,001
| +5% | +$70.4K | ﹤0.01% | 2449 |
|
|
2013
Q3 | $1.13M | Buy |
110,745
+17,437
| +19% | +$163K | ﹤0.01% | 2548 |
|
|
2013
Q2 | $838K | Buy |
+93,308
| New | +$940K | ﹤0.01% | 2685 |
|
TIAA CREF Investment Management's OME Position: Q4 2017 in Review
TIAA CREF Investment Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 228,405 shares — an estimated $3.8M sold.
TIAA CREF Investment Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $4.38M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- TIAA CREF Investment Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- TIAA CREF Investment Management sold 228,405 Omega Protein shares in Q4 2017, an estimated $3.8M.
- TIAA CREF Investment Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- TIAA CREF Investment Management's Omega Protein position peaked at $4.38M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on TIAA CREF Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.